Management of Subseptate Uterus with Infertility or Recurrent Miscarriage
Hysteroscopic septum resection should be considered for women with a subseptate uterus and recurrent miscarriage, as it significantly improves live birth rates and reduces miscarriage rates, particularly in those with recurrent pregnancy loss or primary infertility. 1, 2
Initial Diagnostic Evaluation
Women presenting with infertility or recurrent miscarriage require comprehensive uterine assessment:
- Perform 3D ultrasound as the preferred imaging modality to accurately diagnose and classify the uterine septum, as it has similar accuracy to MRI and is superior to 2D imaging 3, 2
- Sonohysterography (SIS) is an acceptable alternative, demonstrating 100% accuracy in classifying septate, bicornuate, and arcuate uteri 3
- Define the septum using CUME criteria: internal indentation depth ≥10mm qualifies as a septum requiring potential intervention 4
Risk Stratification and Counseling
The decision to proceed with surgery depends on the clinical presentation:
For Recurrent Miscarriage (≥3 first trimester losses or ≥1 second trimester loss):
- Septum resection significantly improves outcomes: live birth rate increases by 77% (RR 1.77,95% CI 1.26-2.49), with postoperative live birth rates of 66% 1
- Miscarriage rates decrease substantially (RR 0.36,95% CI 0.20-0.66) and preterm birth rates drop by 85% (RR 0.15,95% CI 0.04-0.53) 1
- Surgery should be offered within a dedicated recurrent miscarriage clinic setting 2
For Primary Infertility:
- Septum resection improves natural conception: live birth rate increases 4-fold (RR 4.12,95% CI 1.19-14.29) with postoperative live birth rates of 37% 1
- Clinical pregnancy rates more than double (RR 2.28,95% CI 1.04-4.98) 1
- Perform surgery before attempting assisted reproductive technologies (ART), as it improves embryo implantation rates in subsequent IVF cycles 4
For Secondary Infertility:
- Evidence for benefit is unclear, though postoperative live birth rates of 41% have been reported 1
- Consider surgery in cases of recurrent implantation failure following IVF 4
Important Caveat: The Controversy
One high-quality 2021 RCT challenges the benefit of septum resection, showing no difference in live birth rates between surgery (31%) and expectant management (35%) in 79 women with subfertility, pregnancy loss, or preterm birth 5. However, this study has significant limitations:
- Small sample size and prolonged recruitment period
- Mixed population (included women with preterm birth, not just miscarriage/infertility)
- Contradicts multiple cohort studies and meta-analyses showing benefit
The weight of evidence from systematic reviews and meta-analyses supports surgery specifically for recurrent miscarriage and primary infertility 1, 6, 2, while the single RCT's negative findings may reflect population heterogeneity.
Surgical Technique Recommendations
When proceeding with hysteroscopic metroplasty:
- Use intraoperative ultrasound guidance to significantly reduce residual septum >10mm and minimize complications without increasing operative time 7
- Perform complete resection to avoid residual septum, which may perpetuate reproductive dysfunction 7
- Uterine perforation risk is approximately 2.6%, which is acceptable given potential benefits 5
Additional Workup Required
Before attributing reproductive failure solely to the septum:
- Test for antiphospholipid syndrome (lupus anticoagulant and anticardiolipin antibodies) 2
- Obtain thyroid function tests and TPO antibodies 2
- Perform cytogenetic analysis on pregnancy tissue from the third and subsequent miscarriages 2
- Assess BMI and counsel on lifestyle modifications: maintain BMI 19-25 kg/m², smoking cessation, limit alcohol, and caffeine <200mg/day 2
Post-Surgical Management
- Provide supportive care in a dedicated clinic setting for women with recurrent miscarriage 2
- Consider progesterone supplementation (400mg micronized vaginal progesterone twice daily) if bleeding occurs in early pregnancy after conception, continuing until 16 weeks gestation 2
- Monitor for conception within 12 months post-surgery, as this is when maximal benefit is observed 1, 5
When NOT to Operate
Do not perform septum resection for: